CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with Novartis on consumer health, and Novartis’s sale of Novartis Animal Health to Eli Lilly & Co. The deals ultimately went forward with certain divestitures.
SEP licensing in the United States: Understanding the impact on US business
US Business Survey On behalf of ACT | The App Association, consultants with Charles River Associates undertook a survey of US businesses that use technical...